Invention Grant
- Patent Title: Inhibition of Skp2-cyclin a interaction
- Patent Title (中): 抑制Skp2细胞周期蛋白的相互作用
-
Application No.: US12226935Application Date: 2007-05-23
-
Publication No.: US08173604B2Publication Date: 2012-05-08
- Inventor: Liang Zhu , Peng Ji
- Applicant: Liang Zhu , Peng Ji
- Applicant Address: US NY Bronx
- Assignee: Albert Einstein College of Medicine of Yeshiva University
- Current Assignee: Albert Einstein College of Medicine of Yeshiva University
- Current Assignee Address: US NY Bronx
- Agency: Amster Rothstein & Ebenstein LLP
- International Application: PCT/US2007/012277 WO 20070523
- International Announcement: WO2007/139820 WO 20071206
- Main IPC: A61K38/10
- IPC: A61K38/10 ; A61K38/16
Abstract:
Methods of killing a cancer cell are provided. Also provided are methods of treating a subject having a cancer. Additionally, compounds are provided that comprise a peptide from about 18 to about 100 amino acids or peptidomimetics comprising the sequence of SEQ ID NO:1. Additionally provided are methods of screening an agent for the ability to kill a cancer cell.
Public/Granted literature
- US20100075892A1 Inhibition of SKP2-Cyclin a Interaction Public/Granted day:2010-03-25
Information query
IPC分类:
